Current opinion in rheumatology · 2026
Evidence-based follow-up in axial spondyloarthritis: how much is (not) enough?
СтатьяОбзорНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Smits Marius L, Webers Casper, van Tubergen Astrid
Аннотация
PURPOSE OF REVIEW: Present follow-up strategies for axial spondyloarthritis (axSpA) entail frequent preplanned in-person outpatient visits. Capacity constraints make this approach increasingly difficult, and it is plausible that regular follow-up in axSpA is not necessary for all patients. The purpose of this review is to discuss emerging alternative follow-up strategies to improve care efficiency in axSpA, and the challenges of applying these solutions in clinical practice.
RECENT FINDINGS: Patient-initiated follow-up (PIFU) and remote monitoring have been investigated in axSpA in two recent trials. These strategies demonstrated meaningful reductions in the number of outpatient visits and associated healthcare costs in patients with stable (ax)SpA, without negatively affecting health outcomes. Qualitative studies have additionally shown widespread acceptability of PIFU and remote monitoring from the perspective of both patients and healthcare providers, and their ability to enhance self-efficacy of patients. Loss to follow-up, delayed care, and logistical limitations are associated concerns requiring further consideration.
SUMMARY: PIFU and remote monitoring hold potential as effective, efficient, and safe strategies for the follow-up of patients with axSpA. For successful implementation in practice, their inherent challenges must be addressed, including the careful selection and training of patients, and ensuring the necessary infrastructure.
RECENT FINDINGS: Patient-initiated follow-up (PIFU) and remote monitoring have been investigated in axSpA in two recent trials. These strategies demonstrated meaningful reductions in the number of outpatient visits and associated healthcare costs in patients with stable (ax)SpA, without negatively affecting health outcomes. Qualitative studies have additionally shown widespread acceptability of PIFU and remote monitoring from the perspective of both patients and healthcare providers, and their ability to enhance self-efficacy of patients. Loss to follow-up, delayed care, and logistical limitations are associated concerns requiring further consideration.
SUMMARY: PIFU and remote monitoring hold potential as effective, efficient, and safe strategies for the follow-up of patients with axSpA. For successful implementation in practice, their inherent challenges must be addressed, including the careful selection and training of patients, and ensuring the necessary infrastructure.